Paper Details

  1. Home
  2. Paper Details

Anastrozole: a new addition to the armamentarium against advanced breast cancer.

Author: BuzdarA U

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Anastrozole, a new, highly selective, nonsteroidal aromatase inhibitor, was found to be as effective as megestrol acetate for the treatment of advanced breast cancer in postmenopausal women who progressed after tamoxifen therapy.
Paper Details　
Original Abstract of the Article :
Estrogen manipulation represents an effective treatment for advanced breast cancer in postmenopausal women with estrogen-receptor positive disease. The antiestrogen agent, tamoxifen, is the first choice for advanced breast cancer in postmenopausal women due to its efficacy and lack of significant si...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/00000421-199804000-00014

データ提供：米国国立医学図書館（NLM）

Anastrozole: A New Oasis in the Desert of Breast Cancer Treatment

This research explores the role of anastrozole, a new and highly selective aromatase inhibitor, in the treatment of advanced breast cancer in postmenopausal women. The authors compare its effectiveness to other hormonal therapies, such as tamoxifen and megestrol acetate, and investigate its potential to overcome the limitations of existing treatments. Anastrozole offers a convenient once-daily oral dosing regimen and has shown promise in clinical trials.

What Does this Study Suggest?

The study indicates that anastrozole is an effective endocrine agent for treating advanced breast cancer in postmenopausal women who have progressed after tamoxifen therapy. It’s like finding a fresh spring of water in the desert; a new and promising treatment option.

Implications for Health and Lifestyle

This study highlights the importance of staying abreast of new treatment options for breast cancer, as advancements continue to improve patient outcomes. It’s crucial to consult with a healthcare professional to discuss personalized treatment plans and make informed decisions about your health.

Dr.Camel's Conclusion

This research offers a glimmer of hope in the challenging landscape of breast cancer treatment. It demonstrates the power of innovation and the dedication of researchers to find new ways to combat this disease.

Date :
  1. Date Completed 1998-04-14
  2. Date Revised 2019-09-05
Further Info :

Pubmed ID

9537204

DOI: Digital Object Identifier

10.1097/00000421-199804000-00014

Related Literature

Article Analysis
・Side Effects of megestrol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.